Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 4Phase 3 2

Status

Unknown 2Recruiting 2Completed 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 4Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 51Rectal Neoplasms 27Colonic Neoplasms 16Stomach Neoplasms 14Carcinoma, Hepatocellular 14Neoplasm Metastasis 9Adenocarcinoma Of Esophagus 7Esophageal Neoplasms 6Neoplasms 5Cholangiocarcinoma 5Recurrence 3Pancreatic Neoplasms 3Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Adenocarcinoma 3Ovarian Neoplasms 2Liver Neoplasms 2Intestinal Neoplasms 2Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Cirrhosis, Familial, with Pulmonary Hypertension 2Biliary Tract Neoplasms 2Peritoneal Neoplasms 1Pancreatic Adenocarcinoma 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Neurotoxicity Syndromes 1Metastatic Colorectal Adenocarcinoma 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Locally Advanced Colorectal Carcinoma 1Intestinal Diseases 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Folfox protocol × Clear all
NCT06846346 2026-04-28

GRACIE

UNICANCER

Phase 2 Recruiting
88 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Adenocarcinoma, Neoplasm Metastasis, Neoplasms

NCT06475352 2026-04-23

FUDOSE

UNICANCER

Phase 2 Recruiting
400 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasm Metastasis, Neoplasms, Recurrence, Colorectal Neoplasms

NCT02195180 2018-07-27

Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

ERYtech Pharma

Phase 2 Completed
141 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasms

NCT02215837 2016-05-24

Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer

Shenzhen Hornetcorn Bio-technology Company, LTD

Phase 2 Unknown
40 enrolled
Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Neoplasms, Stomach Neoplasms

NCT02202928 2015-12-28

Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer

Shenzhen Hornetcorn Bio-technology Company, LTD

Phase 2 Unknown
60 enrolled
Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Diseases, Intestinal Neoplasms, Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡